Cargando…
The Protective Efficacy of Single-Dose Nasal Immunization with Cold-Adapted Live-Attenuated MERS-CoV Vaccine against Lethal MERS-CoV Infections in Mice
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe diseases in humans. Camels act as intermediate hosts for MERS-CoV. Currently, no licensed vaccine is available for this virus. We have developed a potential candidate vaccine for MERS-CoV using the cold adaptation method. We culti...
Autores principales: | Seo, Heejeong, Jang, Yunyueng, Kwak, Dongmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459767/ https://www.ncbi.nlm.nih.gov/pubmed/37631921 http://dx.doi.org/10.3390/vaccines11081353 |
Ejemplares similares
-
Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2
por: Jang, Yunyueng, et al.
Publicado: (2020) -
MERS-CoV
por: Müller, Marcel A
Publicado: (2014) -
Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023) -
The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014) -
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017)